| INTRODUCTION
The RhD antigen is clinically the most significant blood group antigen for obstetric medicine due to its immunogenicity and the high incidence of RhD-individuals. [1] [2] [3] Depending on the population, 3%-25%
of Caucasians are D−, 4 with 15%-20% prevalence being most commonly reported. 5, 6 Anti-D is still the leading cause of the hemolytic disease of fetus and newborn (HDFN) in the obstetric population of Split-Dalmatian County, Croatia.
7,8
The division between D+ and D− status is not always straightforward, due to over 200 D variant phenotypes having been reported to date. 9 Generally, "weak D" variants are result of mutations in which all D epitopes are present but with reduced expression, while "partial D" represents variants in which the mutations result in the absence of certain polypeptides on the outer RBC surface. 10 Recent research found weak D types to also possess slightly to considerably altered D antigens, with the extent of qualitative changes overlapping with that in partial D. 4 The prevalence of weak D types among Caucasians is reported to be about 0.2%-1%. 4 
| MATERIALS AND METHODS
This study was performed at the Department of Transfusion Medicine 
| Routine typing of D antigen in column technology

| Additional serologic RhD typing
| RHD genotyping
All women whose D antigen in column method during routine serologic D typing was considered to be discrepant were, after the additional 
| Statistical analysis
Statistical analyses were performed using computer software MedCalc ® , version 12.5 (MedCalc Software, Ostend, Belgium).
Relative frequencies and accompanying 95% confidence intervals (95% CI) were used to estimate the prevalence of variants.
| RESULTS
During the period of five years we tested 12 689 primiparous women. (Table 1) . 
| Results of RHD genotyping
| Results of additional serologic analysis of weak D
At the initial routine D typing, the individuals who were later geno- (Table 3 ).
All four cases of samples which showed discrepant results in rou-
tine RhD typing and were initially presumed to be some D variant type, but could not be distinguished from normal D+ in molecular analysis, showed weak agglutination reactions with all five anti-D monoclonal antibodies in tube method. This inability to detect some D weak in molecular analysis is due to the fact that all D weak types were not included in commercial assay (possibly could be done by sequencing). 
| Results of additional serologic analysis of
| DISSCUSION
A recent study showed that RHD genotyping of women with serologi- Microcolumn method is known to be highly sensitive for RhD typing. In this study, the criterion for additional RhD analysis was reactivity in direct agglutination 3+ or less (score of not more than 10)
with one or both anti-D reagents. Of 57 women who fell into the criterion, 53 women were found to be either weak or partial D variants.
Although other studies recommend the cutoff score of not more than 8 (≤2+) by gel technology for assigning D negative status considering transfusion and immunoprophylaxis, 21 the results or our study shows that the reactivity criterion in direct agglutination of score 10 (3+) or less is acceptable as the cutoff value. The frequency of D variants in our study was in concordance with the findings from other studies, and so was the distribution of Rh phenotypes. 4, 6, 10, 13 We found that the most common partial D variant in our popu- Caucasians with frequency between 0.02%-0.05%. 1, 6, 13 Adjusting the reagent choice would be in accordance with suggestions from other authors, stating that the profile of monoclonal antibodies for RhD typing should be chosen individually regarding to the population for which it is used. 15, 22 In our study, DVa category samples could be T A B L E 3 Serologic reactions of D variants with six monoclonal antibodies using set for indirect agglutination ID-Partial (DiaMed) We noticed that reactions of partial D category Va were not entirely in concordance with manufacturer's worksheet in IAT typing with IDpartial typing set (Diamed). As expected, the reaction was omitted with cell line LHM70/45, but unexpectedly also with LHM169/80. This is
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an important finding because it shows that these cell lines should not be used for donor and/or neonate typing as they would type as D−.
Other authors did not report this outcome. 21 12 We were therefore unable to determine the prevalence of partial D variant category DNB in our population, because it was typed as D+ due to our reagent selection criteria. We could conclude that cell line RUM-1 should be used for RhD typing of patients in our population, since it gives weak or negative reactions with partial D category Va category, which we found to be the most prevalent partial D variant in our region. Anti-D reagents should be chosen accordingly to the population's D variants prevalence to recognize D variants which are at risk for immunization.
